Pictured: ESK1 Monoclonal Antibody
In the Lab
New Molecule Targets Proteins Inside Cancer Cells
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, March 13, 2013

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Targeted Therapy; Molecular Pharmacology; Leukemias; Research
25 comments
Pictured: Structure of Synthesized Erythropoietin
In the Lab
Memorial Sloan-Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time
By Julie Grisham, MS, Science Writer/Editor  |  Monday, October 8, 2012

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

Chemistry; Molecular Pharmacology; Research
13 comments
Pictured: Structural formula of IBNtxA
In the Lab
Findings Could Lead to the Development of a New Painkiller
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 13, 2011

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

Drug Discovery; Pain Management; Molecular Pharmacology; Research
Add a Comment

Featured Blog Posts

Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment
A Single Early PSA Test Found to Predict Long-Term Risk of Aggressive Prostate Cancer
Memorial Sloan-Kettering Experts Discuss Awake Surgery for Brain Tumors

Center News

Pictured: Center News, April 2013
Read Our Magazine »

Subscribe to Our E-newsletter

Get the latest information about cancer care.